Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Ruetsch

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Population Health Management|April 1, 2016
Assessment of Rheumatoid Arthritis Quality Process Measures and Associated CostsBrenna L Brady, Joseph Tkacz, Roxanne Meyer, et al.
American Health & Drug Benefits|February 3, 2016
Novel Adherence Measures for Infusible Therapeutic Agents Indicated for Rheumatoid ArthritisJoseph Tkacz, Michael P Ingham, Brenna L Brady, et al.
Journal of Pain Research|March 6, 2013
Trajectories of health care service utilization and differences in patient characteristics among adults with specific chronic pain: analysis of health plan member claimsCharles Ruetsch, Joseph Tkacz, Peter G Kardel, et al.
Clinical Therapeutics|March 26, 2014
Utilization and adherence patterns of subcutaneously administered anti-tumor necrosis factor treatment among rheumatoid arthritis patientsJoseph Tkacz, Lorie Ellis, Susan C Bolge, et al.
Clinicoeconomics and Outcomes Research : CEOR|November 10, 2021
Comparison of Healthcare Resource Utilization Between Patients Who Engaged or Did Not Engage With a Prescription Digital Therapeutic for Opioid Use DisorderFulton F Velez, Sam Colman, Laura Kauffman, et al.
Health Services Research and Managerial Epidemiology|July 14, 2022
Impact of the COVID-19 Pandemic on Healthcare Resource Utilization in Individuals with Major Depressive DisorderJoshua N Liberman, Sandipan Bhattacharjee, Pinyao Rui, et al.
Journal of Managed Care & Specialty Pharmacy|January 24, 2015
Quality process measures for rheumatoid arthritis: performance from members enrolled in a national health planJoseph Tkacz, Lorie A Ellis, Roxanne Meyer, et al.
Clinical Schizophrenia & Related Psychoses|November 23, 2017
Relapse Risk Assessment for Schizophrenia Patients (RASP): A New Self-Report Screening ToolDawn Velligan, William Carpenter, Heidi C Waters, et al.
Journal of Managed Care & Specialty Pharmacy|November 2, 2015
An Assessment of the AGA and CCFA Quality Indicators in a Sample of Patients Diagnosed with Inflammatory Bowel DiseaseJoseph Tkacz, Brenna L Brady, Roxanne Meyer, et al.
Advances in Therapy|July 12, 2022
Real-World Reductions in Healthcare Resource Utilization over 6 Months in Patients with Substance Use Disorders Treated with a Prescription Digital TherapeuticNeel Shah, Fulton F Velez, Samuel Colman, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Population Health Management|April 1, 2016
Assessment of Rheumatoid Arthritis Quality Process Measures and Associated CostsBrenna L Brady, Joseph Tkacz, Roxanne Meyer, et al.
American Health & Drug Benefits|February 3, 2016
Novel Adherence Measures for Infusible Therapeutic Agents Indicated for Rheumatoid ArthritisJoseph Tkacz, Michael P Ingham, Brenna L Brady, et al.
Journal of Pain Research|March 6, 2013
Trajectories of health care service utilization and differences in patient characteristics among adults with specific chronic pain: analysis of health plan member claimsCharles Ruetsch, Joseph Tkacz, Peter G Kardel, et al.
Clinical Therapeutics|March 26, 2014
Utilization and adherence patterns of subcutaneously administered anti-tumor necrosis factor treatment among rheumatoid arthritis patientsJoseph Tkacz, Lorie Ellis, Susan C Bolge, et al.
Clinicoeconomics and Outcomes Research : CEOR|November 10, 2021
Comparison of Healthcare Resource Utilization Between Patients Who Engaged or Did Not Engage With a Prescription Digital Therapeutic for Opioid Use DisorderFulton F Velez, Sam Colman, Laura Kauffman, et al.
Health Services Research and Managerial Epidemiology|July 14, 2022
Impact of the COVID-19 Pandemic on Healthcare Resource Utilization in Individuals with Major Depressive DisorderJoshua N Liberman, Sandipan Bhattacharjee, Pinyao Rui, et al.
Journal of Managed Care & Specialty Pharmacy|January 24, 2015
Quality process measures for rheumatoid arthritis: performance from members enrolled in a national health planJoseph Tkacz, Lorie A Ellis, Roxanne Meyer, et al.
Clinical Schizophrenia & Related Psychoses|November 23, 2017
Relapse Risk Assessment for Schizophrenia Patients (RASP): A New Self-Report Screening ToolDawn Velligan, William Carpenter, Heidi C Waters, et al.
Journal of Managed Care & Specialty Pharmacy|November 2, 2015
An Assessment of the AGA and CCFA Quality Indicators in a Sample of Patients Diagnosed with Inflammatory Bowel DiseaseJoseph Tkacz, Brenna L Brady, Roxanne Meyer, et al.
Advances in Therapy|July 12, 2022
Real-World Reductions in Healthcare Resource Utilization over 6 Months in Patients with Substance Use Disorders Treated with a Prescription Digital TherapeuticNeel Shah, Fulton F Velez, Samuel Colman, et al.
Pageof 4